Drug Type Small molecule drug |
Synonyms D 0870, D-0870, ICI D 0870 + [4] |
Target |
Action inhibitors |
Mechanism CYP51A1 inhibitors(Cytochrome P450 51 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H20F6N6O2 |
InChIKeyFZEJTXCSLUORDW-DHXBXMGCSA-N |
CAS Registry149715-95-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Mycoses | Phase 2 | United States | - | - |
| Mycoses | Phase 2 | Japan | - | |
| Mycoses | Phase 2 | Belgium | - | - |
| Mycoses | Phase 2 | France | - | - |
| Mycoses | Phase 2 | Germany | - | - |
| Mycoses | Phase 2 | Netherlands | - | - |
| Mycoses | Phase 2 | United Kingdom | - | |
| Mycoses | Phase 2 | - | - | |
| Chagas Disease | Preclinical | Venezuela | - | - |





